Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000306
Chunk: 99

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 99
---
 to payment hereunder.
No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon. For the purposes
hereof, an Event of Default relating to default in payment is “continuing” if it has not been waived, and an Event
of Default relating to circumstances other than a default in payment is “continuing” if it has not been remedied or
waived.

(3) .

(a) . If this
Note is to be transferred, the Holder shall surrender this Note to the Company, whereupon the Company will forthwith issue and deliver
upon the order of the Holder a new Note (in accordance with Section (3)(d)), registered in the name of the registered transferee or assignee,
representing the outstanding Principal being transferred by the Holder (along with any accrued and unpaid interest thereof) and, if less
than the entire outstanding Principal is being transferred, a new Note (in accordance with Section (3)(d)) to the Holder representing
the outstanding Principal not being transferred.

(b) . Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary
form and, in the case of mutilation, upon surrender and cancellation of this Note, the Company shall execute and deliver to the Holder
a new Note (in accordance with Section (3)(d)) representing the outstanding Principal.

(c) . This Note is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Note or Notes (in accordance with Section (3)(d)) representing in the aggregate the outstanding Principal of this Note, and
each such new Note will represent such portion of such outstanding Principal as is designated by the Holder at the time of such surrender.

(d) .
Whenever the Company is required to issue a new Note pursuant to the terms hereof, such new Note (i) shall be of like tenor with this
Note, (ii) shall represent, as indicated on the face of such new Note, the Principal remaining outstanding, (iii) shall have an issuance
date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have the same rights
and conditions as this Note, and (v) shall represent accrued